tiprankstipranks
Trending News
More News >
Bioatla, Inc. (BCAB)
:BCAB
US Market

BioAtla (BCAB) Technical Analysis

Compare
544 Followers

Technical Sentiment

Overall Consensus
Neutral
7Bullish
5Neutral
9Bearish
Technical Analysis Consensus
Sell
1Bullish
5Neutral
3Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Bioatla, Inc.’s (BCAB) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting Bioatla, Inc. is a Sell.
Bioatla, Inc.’s (BCAB) 20-Day exponential moving average is 0.33, while Bioatla, Inc.’s (BCAB) share price is $0.34, making it a Buy.
Bioatla, Inc.’s (BCAB) 50-Day exponential moving average is 0.40, while Bioatla, Inc.’s (BCAB) share price is $0.34, making it a Sell.

BioAtla (BCAB) Pivot Points

Apr 23, 2025, 11:17 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.27
0.29
0.31
0.33
0.35
0.37
0.39
Fibonacci
0.29
0.30
0.31
0.33
0.34
0.35
0.37
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

BioAtla (BCAB) Moving Averages

Apr 23, 2025, 11:17 AM
Period
Simple
Exponential
MA5
0.33Buy
0.33Buy
MA10
0.31Buy
0.32Buy
MA20
0.33Buy
0.33Buy
MA50
0.35Sell
0.40Sell
MA100
0.62Sell
0.65Sell
MA200
1.20Sell
1.13Sell
Bioatla, Inc.’s (BCAB) 10-Day exponential moving average is 0.32, while Bioatla, Inc.’s (BCAB) share price is $0.34, making it a Buy.
Bioatla, Inc.’s (BCAB) 100-Day exponential moving average is 0.65, while Bioatla, Inc.’s (BCAB) share price is $0.34, making it a Sell.
Bioatla, Inc.’s (BCAB) stock price is $0.34 and Bioatla, Inc.’s (BCAB) 50-day simple moving average is 0.35, creating a Sell signal.
Bioatla, Inc.’s (BCAB) stock price is $0.34 and Bioatla, Inc.’s (BCAB) 100-day simple moving average is 0.62, creating a Sell signal.
Bioatla, Inc.’s (BCAB) stock price is $0.34 and Bioatla, Inc.’s (BCAB) 200-day simple moving average is 1.20, creating a Sell signal.

BioAtla (BCAB) Technical Indicators

Apr 23, 2025, 11:17 AM
Name
Value
Implied Action
RSI (14)
54.06
Neutral
STOCH (9,6)
87.14
Sell
STOCHRSI (14)
72.92
Neutral
MACD (12,26)
-0.01
Sell
ADX (14)
23.60
Neutral
Williams %R
-13.46
Sell
CCI (14)
41.71
Neutral
ATR (14)
0.04
-
Ultimate Oscillator
63.48
Neutral
ROC
0.00
Sell
Bioatla, Inc.’s (BCAB) Relative Strength Index (RSI) is 54.06, creating a Neutral signal.
Bioatla, Inc.’s (BCAB) Trend Strength Indicator (ADX) is 23.60, creating a Neutral signal.
Bioatla, Inc.’s (BCAB) Commodity Channel Index (CCI) is 41.71, creating a Neutral signal.

FAQ

Is BCAB a Buy, Hold, or Sell?
Based on BCAB’s technical indicators, BCAB is a Hold.
    What is BCAB’s RSI (14)?
    BCAB’s RSI (14) is 54.06, which suggests BCAB is a Neutral.
      What is BCAB’s MACD?
      BCAB’s MACD is -0.01, which suggests BCAB is a Sell.
        What is BCAB’s 5-day moving average?
        BCAB’s 5-day moving average is 0.33, which suggests BCAB is a Buy.
          What is BCAB’s 20-day moving average?
          BCAB 20-day moving average is 0.33, which suggests BCAB is a Buy.
            What is BCAB’s 50-day moving average?
            BCAB’s 50-day moving average is 0.35, which suggests BCAB is a Sell.
              What is BCAB’s 200-day moving average?
              BCAB’s 200-day moving average is 1.20, which suggests BCAB is a Sell.
                What is BCAB’s Williams % R (14)?
                BCAB’s Williams % R (14) is -13.46, which suggests BCAB is a Sell.
                  What is BCAB’s CCI (14)?
                  BCAB’s CCI (14) is 41.71, which suggests BCAB is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis